Niagen Bioscience, Inc. (NAGE) — Free Cash Flow Generation Index

Latest as of September 2025: 0.99x

Niagen Bioscience, Inc. (NAGE) has a Free Cash Flow Generation Index of 0.99x as of September 2025. Free cash flow of $3.67 Million represents 1% of operating cash flow ($3.69 Million). See Niagen Bioscience, Inc. (NAGE) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

$3.67 Million
USD

Operating Cash Flow

$3.69 Million
USD

Capital Expenditures

$24.00K
USD

Niagen Bioscience, Inc. Free Cash Flow Generation Index (2023–2024)

Historical FCF Generation Index trend for Niagen Bioscience, Inc. across 2 annual periods. Explore how well can Niagen Bioscience, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Niagen Bioscience, Inc. (2023–2024)

Year-by-year Free Cash Flow Generation Index for Niagen Bioscience, Inc.. For the full company profile including market capitalisation, see Niagen Bioscience, Inc. market cap and net worth.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2024 0.99x $11.95 Million $12.11 Million $163.00K ▲ +0.7%
2023 0.98x $6.97 Million $7.12 Million $148.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).